Jing-Yu Lang

821 total citations
7 papers, 331 citations indexed

About

Jing-Yu Lang is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Jing-Yu Lang has authored 7 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pharmacology. Recurrent topics in Jing-Yu Lang's work include Phytochemical compounds biological activities (2 papers), Cancer-related Molecular Pathways (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Jing-Yu Lang is often cited by papers focused on Phytochemical compounds biological activities (2 papers), Cancer-related Molecular Pathways (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Jing-Yu Lang collaborates with scholars based in United States, Taiwan and Canada. Jing-Yu Lang's co-authors include Mien‐Chie Hung, K. Sengupta, Aditi Banerjee, Dipak Banerjee, Sushanta K. Banerjee, Krishna Baksi, Jennifer L. Hsu, Xiaoming Xie, Pei-Chi Wu and Susan L. Morris‐Natschke and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Cell and Cancer Research.

In The Last Decade

Jing-Yu Lang

7 papers receiving 328 citations

Peers

Jing-Yu Lang

MB

ONCOL

OC

PHARM

CB

Michael V. Fiandalo United States

Romina M. Wiedmann Germany

Katayoun A. Jessen United States

Qiuming Pan China

Cindy Grandjenette South Korea

Chanlu Xie Australia

Perry Dhaliwal India

Chee Onn Leong Malaysia

Laura Biddick United States

Zuohe Song United States

Michael V. Fiandalo United States

Jing-Yu Lang

268 ×1.4

MB

72 ×0.9

ONCOL

82 ×1.2

OC

53 ×1.1

PHARM

23 ×0.6

CB

Citations per year, relative to Jing-Yu Lang Jing-Yu Lang (= 1×) peers Michael V. Fiandalo

Countries citing papers authored by Jing-Yu Lang

Since Specialization

Citations

This map shows the geographic impact of Jing-Yu Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing-Yu Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing-Yu Lang more than expected).

Fields of papers citing papers by Jing-Yu Lang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing-Yu Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing-Yu Lang. The network helps show where Jing-Yu Lang may publish in the future.

Co-authorship network of co-authors of Jing-Yu Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Jing-Yu Lang. A scholar is included among the top collaborators of Jing-Yu Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing-Yu Lang. Jing-Yu Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lang, Jing-Yu, Jennifer L. Hsu, Funda Meric‐Bernstam, et al.. (2011). BikDD Eliminates Breast Cancer Initiating Cells and Synergizes with Lapatinib for Breast Cancer Treatment. Cancer Cell. 20(3). 341–356. 62 indexed citations

2.

Banerjee, Aditi, Jing-Yu Lang, Mien‐Chie Hung, et al.. (2011). Unfolded Protein Response Is Required in nu/nu Mice Microvasculature for Treating Breast Tumor with Tunicamycin. Journal of Biological Chemistry. 286(33). 29127–29138. 82 indexed citations

3.

Cheng, Xiaoyun, Weiya Xia, Jer-Yen Yang, et al.. (2010). Activation of Murine Double Minute 2 by Akt in Mammary Epithelium Delays Mammary Involution and Accelerates Mammary Tumorigenesis. Cancer Research. 70(19). 7684–7689. 16 indexed citations

4.

Usami, Yoshihide, Kyoko Nakagawa‐Goto, Jing-Yu Lang, et al.. (2010). Antitumor Agents. 282. 2′-(R)-O-Acetylglaucarubinone, a Quassinoid fromOdyendyea gabonensisAs a Potential Anti-Breast and Anti-Ovarian Cancer Agent. Journal of Natural Products. 73(9). 1553–1558. 16 indexed citations

5.

Dong, Yizhou, Qian Shi, Chieh-Yu Peng, et al.. (2010). Antitumor Agents. 272. Structure−Activity Relationships and In Vivo Selective Anti-Breast Cancer Activity of Novel Neo-tanshinlactone Analogues. Journal of Medicinal Chemistry. 53(5). 2299–2308. 63 indexed citations

6.

Dong, Yizhou, Qian Shi, Kyoko Nakagawa‐Goto, et al.. (2009). Antitumor agents 270. Novel substituted 6-phenyl-4H-furo[3,2-c]pyran-4-one derivatives as potent and highly selective anti-breast cancer agents. Bioorganic & Medicinal Chemistry. 18(2). 803–808. 31 indexed citations

7.

Xie, Xiaoming, Weiya Xia, Zhongkui Li, et al.. (2007). Targeted Expression of BikDD Eradicates Pancreatic Tumors in Noninvasive Imaging Models. Cancer Cell. 12(1). 52–65. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact